Reblozyl (luspatercept)

pCPA File Number: 21506
Negotiation Status:
Concluded with an LOI
Indication(s):
beta-thalassemia associated anemia
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0669
pCPA Engagement Letter Issued:
Negotiation Process Concluded: